Sydney Investor Lunch Showcases ASX Health and MedTech Pitches

Jane Morgan Management marked its 20th anniversary with an East Coast Investor Lunch at Sydney’s The Establishment. More than 130 investors heard 11 ASX‑listed companies make ten‑minute pitches, reflecting a sector split of six health and medtech firms, four resources companies and one defence player.

Key health‑tech presenters included BlinkLab, which is developing a smartphone‑based AI platform to aid autism diagnosis; NeuroScientific Biopharmaceuticals, working on mesenchymal‑stem‑cell cellular therapies for inflammatory diseases; Cleo Diagnostics, offering a blood‑based CXCL10 test to differentiate benign from malignant ovarian masses; Identifai Genetics, proposing a prenatal AI‑driven genetic risk assessment; and Botanix Pharmaceuticals, preparing to commercialise the FDA‑approved drug Sofdra. The event opened with comments from independent analyst Jason Segal and a market‑optimistic keynote by Freddie Cator of Jarden, noting a more upbeat outlook for Australian small‑ and mid‑cap equities.

The pitches underscored growing investor interest in AI‑driven diagnostics and biotech innovations within the Australian market.